RP
Regeneron Pharmaceuticals Portfolio holdings
AUM
$1.49B
This Quarter Return
-15.69%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.09B
AUM Growth
–
Cap. Flow
+$1.09B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$1.05B |
| 2 |
Intellia Therapeutics
NTLA
|
+$43.2M |
| 3 |
TSVT
2seventy bio
TSVT
|
+$3.69M |
| 4 |
Adicet Bio
ACET
|
+$931K |
| 5 |
Adverum Biotechnologies
ADVM
|
+$845K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alnylam Pharmaceuticals
ALNY
$60.8B
| $1.05B | 95.54% |
+4,444,445
| New | +$1.05B |
|
|
2
Intellia Therapeutics
NTLA
$1.28B
| $43.2M | 3.94% |
+3,702,995
| New | +$43.2M |
|
|
TSVT
3
DELISTED
2seventy bio
TSVT
| $3.69M | 0.34% |
+1,254,827
| New | +$3.69M |
|
|
4
Adicet Bio
ACET
$67.7M
| $931K | 0.09% |
+968,183
| New | +$931K |
|
|
5
Adverum Biotechnologies
ADVM
$64.2M
| $845K | 0.08% |
+180,909
| New | +$845K |
|
|
BLUE
6
DELISTED
bluebird bio
BLUE
| $175K | 0.02% |
+21,000
| New | +$175K |
|